1 / 13

TBTEAM Global Support: Phase II renewal planning & new funding component

TBTEAM Global Support: Phase II renewal planning & new funding component. Dr Malgosia Grzemska STB Department WHO/HQ Regional Workshop on TB Control Planning, Implementation and Monitoring Jakarta, Indonesia, 29-31 May 2012. Phase 2 renewal planning.

lukas
Download Presentation

TBTEAM Global Support: Phase II renewal planning & new funding component

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. TBTEAM Global Support: Phase II renewal planning & new funding component Dr Malgosia Grzemska STB Department WHO/HQ Regional Workshop on TB Control Planning, Implementation and Monitoring Jakarta, Indonesia, 29-31 May 2012

  2. Phase 2 renewal planning • Phase 1: The first 18 months performance of the 24 month grant are assessed during last 6 months. • After 18 months: • Pre-CCM request (month 18) • Letter to CCM from GF Secretariat • CCM letter (month 21) • LFA letter (month 22) • GF Secretariat scoring of the grant and reworking the submission with cuts (month 23) • Phase 2 Panel makes recommendations to the Board (month 23) • Board decides. (month 24 onwards)

  3. Process Overview

  4. The pitfalls that can cause your grant to be downgraded • Poor performance of performance framework indicators. • Under utilization of the grants finances " burn rate" • Issues around data quality and M&E • Issues around procurement and health product management. • Issues around Financial system and programme management • No evidence of impact of the program on disease.

  5. GRANT PERFORMANCE RATING • Programmatic achievements(step 1) provide the initial PR performance rating • However, this rating may be adjusted downwards due to major risksrelated to data quality and/or SSF management (steps 2 and 3) • Downgrades are not automatically cumulative. Major risks should generally result in one point downgrade. • Indicator rating of B1 is downgraded to B2 because there are major risks in financial management PHPM = Pharmaceutical and Health Product management

  6. What is the financial implication of a grant downgrading?

  7. Phase 2 renewals • Performance based funding cut (on top of 10% "efficiency" savings) • the 25% efficiency savings are on hold for UL middle income countries In Oct 2011 of 113 TB grants 2% were C and 12% B2

  8. SEARO grants for renewal in 2012

  9. Implications for TA: • TA needs to influence performance indicators and management issues in the first 18 months to safeguard phase 2 money. • Partners and WHO being asked for additional information to inform the Phase 2 renewal. A programme review or smaller scale mission also looking at impact could be helpful. • Support NTP in reviewing what things might be strategic investments in Phase 2 • TA for up to 6 months to support the CCM/PR prepare funding request & justification, and to follow this request throughout the iterative process when the Global Fund Secretariat discusses further performance based strategic reprogramming.

  10. What TBTEAM (national/regional/ HQ) can facilitate • Supportive TA in first 18 months- • addressing CPs and performance indicators, management letter indicating risks • Update strategic plans • At 18 months: conference call with PR, partners and FPMs to discuss needs for TA. • Schedule reviews if possible to precede phase 2 renewals. • For priority grants: identify lead consultant to support country throughout phase 2 process.

  11. Decision Point GF/B26/DP6: • 1. Given the new and encouraging financial forecasts presented to the Global Fund’s Board at its Twenty-Sixth Meeting in Geneva in May 2012, the Board decides to accelerate the implementation of the new Global Fund Strategy ‘Investing for Impact’ by opening new funding opportunities starting in late September 2012 to allow for Board funding decisions to be made no later than the end of April 2013.

  12. Decision Point GF/B26/DP6: • 2. The Secretariat, under the guidance of the Strategy, Investment and Impact Committee (‘SIIC’), will design in consultation with countries, partners and other stakeholders, the elements of the new funding models, including the structure and parameters of the new ‘iterative process’, options for distribution of funds available, and other elements, and the SIIC will bring its recommendation to a special Board meeting in September 2012.

  13. New funding opportunityBoard meeting May 2012 Geneva • there is around 1 billion in uncommitted funding that could be used for new grants. • this is on top of TFM approved funding 615 million. (of which 130 million for TB). Currently GF checking on eligibility and TRP review in June. • Global Fund is looking for a new mechanism for strategic investments and wants to move away from round based funding.

More Related